Azenta, Inc. (AZTA) is a publicly traded Healthcare sector company. As of May 21, 2026, AZTA trades at $18.49 with a market cap of $748.55M and a P/E ratio of -4.85. AZTA moved +5.27% today. Year to date, AZTA is -48.06%; over the trailing twelve months it is -34.31%. Its 52-week range spans $15.93 to $55.64. Analyst consensus is strong buy with an average price target of $30.75. Rallies surfaces AZTA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Azenta Cuts FY26 Guidance to $603–621M, Extends Growth Plan to 2029: Azenta reported Q2 revenue of $145 million, up 1% year-over-year, with organic revenue down 3% and adjusted EBITDA falling 39% to $8 million. It cut FY26 guidance to $603–621 million revenue, now forecasting a 0–125 bps EBITDA margin decline, and extended its long-range plan to 2029.
| Metric | Value |
|---|---|
| Price | $18.49 |
| Market Cap | $748.55M |
| P/E Ratio | -4.85 |
| EPS | $-3.77 |
| Dividend Yield | 0.10% |
| 52-Week High | $55.64 |
| 52-Week Low | $15.93 |
| Volume | 2.87K |
| Avg Volume | 0 |
| Revenue (TTM) | $596.48M |
| Net Income | $-173.34M |
| Gross Margin | 44.33% |
4 analysts cover AZTA: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $30.75.